11/23: StreetInsider.com Unusual 8 Morning Movers:

Alexion Pharm (Nasdaq: ALXN) 25.61% LOWER; Phase III trial of Pexelizumab missed its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE